These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11911015)

  • 1. Inhibition of human angiogenesis with heparin and hydrocortisone.
    Jung SP; Siegrist B; Wade MR; Anthony CT; Woltering EA
    Angiogenesis; 2001; 4(3):175-86. PubMed ID: 11911015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of human Angiostatin protein on human angiogenesis in vitro.
    Jung SP; Siegrist B; Wang YZ; Wade MR; Anthony CT; Hornick C; Woltering EA
    Angiogenesis; 2003; 6(3):233-40. PubMed ID: 15041799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of human recombinant Endostatin protein on human angiogenesis.
    Jung SP; Siegrist B; Hornick CA; Wang YZ; Wade MR; Anthony CT; Woltering EA
    Angiogenesis; 2002; 5(1-2):111-8. PubMed ID: 12549868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel in vitro assay for human angiogenesis.
    Brown KJ; Maynes SF; Bezos A; Maguire DJ; Ford MD; Parish CR
    Lab Invest; 1996 Oct; 75(4):539-55. PubMed ID: 8874385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An assay to measure angiogenesis in human fat tissue.
    Greenway FL; Liu Z; Yu Y; Caruso MK; Roberts AT; Lyons J; Schwimer JE; Gupta AK; Bellanger DE; Guillot TS; Woltering EA
    Obes Surg; 2007 Apr; 17(4):510-5. PubMed ID: 17608264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colchicine and 2-methoxyestradiol Inhibit Human Angiogenesis.
    Stafford SJ; Schwimer J; Anthony CT; Thomson JL; Wang YZ; Woltering EA
    J Surg Res; 2005 May; 125(1):104-8. PubMed ID: 15836858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-angiogenic activity of heparin-like polysulfonated polymeric drugs in 3D human cell culture.
    García-Fernández L; Halstenberg S; Unger RE; Aguilar MR; Kirkpatrick CJ; San Román J
    Biomaterials; 2010 Nov; 31(31):7863-72. PubMed ID: 20674006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of angiogenic initiation and disruption of newly established human vascular networks by juice from Morinda citrifolia (noni).
    Hornick CA; Myers A; Sadowska-Krowicka H; Anthony CT; Woltering EA
    Angiogenesis; 2003; 6(2):143-9. PubMed ID: 14739620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LHT7, a chemically modified heparin, inhibits multiple stages of angiogenesis by blocking VEGF, FGF2 and PDGF-B signaling pathways.
    Chung SW; Bae SM; Lee M; Al-Hilal TA; Lee CK; Kim JK; Kim IS; Kim SY; Byun Y
    Biomaterials; 2015 Jan; 37():271-8. PubMed ID: 25453957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-tumor and anti-angiogenic effects in mice of heparin conjugated to angiostatic steroids.
    Derbyshire EJ; Comin GA; Yang YC; Overholser J; Watkins L; Thorpe PE
    Int J Cancer; 1995 Nov; 63(5):694-701. PubMed ID: 7591287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiangiogenic potential of camptothecin and topotecan.
    Clements MK; Jones CB; Cumming M; Daoud SS
    Cancer Chemother Pharmacol; 1999; 44(5):411-6. PubMed ID: 10501915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro antiangiogenic effect of sandostatin (octreotide) on the proliferation of the placental vessels.
    Zalatnai A; Timár F
    Anticancer Res; 2002; 22(6C):4225-7. PubMed ID: 12553061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of vascular growth factors on arterial and venous angiogenesis.
    Blebea J; Vu JH; Assadnia S; McLaughlin PJ; Atnip RG; Zagon IS
    J Vasc Surg; 2002 Mar; 35(3):532-8. PubMed ID: 11877704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of AlloDerm on the initiation and growth of human neovessels.
    Weiss SR; Tenney JM; Thomson JL; Anthony CT; Chiu ES; Friedlander PL; Woltering EA
    Laryngoscope; 2010 Mar; 120(3):443-9. PubMed ID: 20131371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unfractionated and low molecular weight heparin affect fibrin structure and angiogenesis in vitro.
    Collen A; Smorenburg SM; Peters E; Lupu F; Koolwijk P; Van Noorden C; van Hinsbergh VW
    Cancer Res; 2000 Nov; 60(21):6196-200. PubMed ID: 11085545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral delivery of a potent anti-angiogenic heparin conjugate by chemical conjugation and physical complexation using deoxycholic acid.
    Alam F; Al-Hilal TA; Chung SW; Seo D; Mahmud F; Kim HS; Kim SY; Byun Y
    Biomaterials; 2014 Aug; 35(24):6543-52. PubMed ID: 24816287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of human endothelial cell proliferation by heparin and steroids.
    Cariou R; Harousseau JL; Tobelem G
    Cell Biol Int Rep; 1988 Dec; 12(12):1037-47. PubMed ID: 2852064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effects of bevacizumab, ranibizumab and pegaptanib at intravitreal dose range on endothelial cells.
    Carneiro A; Falcão M; Pirraco A; Milheiro-Oliveira P; Falcão-Reis F; Soares R
    Exp Eye Res; 2009 Mar; 88(3):522-7. PubMed ID: 19135441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suramin analogs inhibit human angiogenesis in vitro.
    Meyers MO; Gagliardi AR; Flattmann GJ; Su JL; Wang YZ; Woltering EA
    J Surg Res; 2000 Jun; 91(2):130-4. PubMed ID: 10839961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiogenesis model for ultrasound contrast research: exploratory study.
    Lucidarme O; Nguyen T; Kono Y; Corbeil J; Choi SH; Varner J; Mattrey RF
    Acad Radiol; 2004 Jan; 11(1):4-12. PubMed ID: 14746396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.